Literature DB >> 30537026

Obesity-induced CYP2E1 activity in children.

Christina Gade1, Kim Dalhoff1, Tonny Petersen1, Troels Riis1, Camilla Schmeltz2, Elizaveta Chabanova3, Hanne Rolighed Christensen1, Gerd Mikus4, Juergen Burhenne4, Jens Christian Holm2,5, Helle Holst1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30537026      PMCID： PMC6339961          DOI： 10.1111/bcp.13813

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase.

Authors:  Carl M Oneta; Charles S Lieber; JunJie Li; Sigmund Rüttimann; Beat Schmid; Jürg Lattmann; Alan S Rosman; Helmut K Seitz
Journal:  J Hepatol       Date:  2002-01       Impact factor: 25.083

2.  Obesity-induced CYP2E1 activity in children.

Authors:  Christina Gade; Kim Dalhoff; Tonny Petersen; Troels Riis; Camilla Schmeltz; Elizaveta Chabanova; Hanne Rolighed Christensen; Gerd Mikus; Juergen Burhenne; Jens Christian Holm; Helle Holst
Journal:  Br J Clin Pharmacol       Date:  2018-12-09       Impact factor: 4.335

3.  CYP2E1 activity and children with obesity: possible confounding factors.

Authors:  Hardeep Kaur; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Br J Clin Pharmacol       Date:  2018-10-17       Impact factor: 4.335

4.  Cytochrome P-450 2E1 activity and oxidative stress in alcoholic patients.

Authors:  I Dupont; P Bodénez; F Berthou; B Simon; L G Bardou; D Lucas
Journal:  Alcohol Alcohol       Date:  2000-01       Impact factor: 2.826

5.  Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.

Authors:  D Lucas; R Ferrara; E Gonzalez; P Bodenez; A Albores; M Manno; F Berthou
Journal:  Pharmacogenetics       Date:  1999-06

Review 6.  Cytochrome P-4502E1: its physiological and pathological role.

Authors:  C S Lieber
Journal:  Physiol Rev       Date:  1997-04       Impact factor: 37.312

7.  Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.

Authors:  Lena Ernstgård; Margareta Warholm; Gunnar Johanson
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

8.  The CYTONOX trial.

Authors:  Christina Gade; Gerd Mikus; Hanne Rolighed Christensen; Kim Peder Dalhoff; Jens-Christian Holm; Helle Holst
Journal:  Dan Med J       Date:  2016-05       Impact factor: 1.240

9.  Higher chlorzoxazone clearance in obese children compared with nonobese peers.

Authors:  C Gade; K Dalhoff; T S Petersen; T Riis; C Schmeltz; E Chabanova; H R Christensen; G Mikus; J Burhenne; J C Holm; H Holst
Journal:  Br J Clin Pharmacol       Date:  2018-06-03       Impact factor: 4.335

10.  Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase.

Authors:  D Lucas; C Ménez; C Girre; P Bodénez; E Hispard; J F Ménez
Journal:  Alcohol Clin Exp Res       Date:  1995-04       Impact factor: 3.455
View more
  1 in total

1.  Obesity-induced CYP2E1 activity in children.

Authors:  Christina Gade; Kim Dalhoff; Tonny Petersen; Troels Riis; Camilla Schmeltz; Elizaveta Chabanova; Hanne Rolighed Christensen; Gerd Mikus; Juergen Burhenne; Jens Christian Holm; Helle Holst
Journal:  Br J Clin Pharmacol       Date:  2018-12-09       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.